Pfizer has "accelerated the production" of its vaccine against Covid-19 and will be able to supply the United States by the end of May with 10% more doses than currently planned, said the boss of the American laboratory, Albert Bourla, on Tuesday. on Twitter.
The group, which developed the serum with BioNTech, could also "provide all of the 300 million (doses) agreed for late July two weeks in advance," he added.
. @ Pfizer has ramped up production of our # COVID19 vaccine & can deliver 10% more doses to the US by the end of May than previously agreed (total of 220M) & supply the full 300M agreed on for the end of July two weeks early .
In the fight against COVID-19, we're in this together.
- AlbertBourla (@AlbertBourla) April 13, 2021
The US health authorities decided earlier today to recommend a "pause" in the use of the Covid-19 vaccine from the Johnson & Johnson laboratory, the time to investigate the appearance of serious cases of blood clots in several people in the United States.
"Vaccine reserves have become more abundant"
One case turned out to be fatal.
This recommendation should not have "significant impact" on the vaccination campaign in the United States, said Tuesday the White House.
US President Joe Biden has promised the country will have enough doses for all adults in the country by "the end of May".
"The reserves of vaccines have become more abundant," confirmed Peter Marks, one of the officials of the United States Medicines Agency (FDA), at a press conference.
In addition to the 300 million doses of the Pfizer / BioNTech vaccine for the end of July, the government has placed an order for 300 million doses of the Moderna vaccine for the same deadline.
Washington has also ordered 100 million doses from Johnson & Johnson.